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The use of antibiotics in food-producing animals has significantly increased animal
health by lowering mortality and the incidence of diseases. Antibiotics also have largely
contributed to increase productivity of farms. However, antibiotic usage in general and
relevance of non-therapeutic antibiotics (growth promoters) in feed need to be reevaluated
especially because bacterial pathogens of humans and animals have developed and shared
a variety of antibiotic resistance mechanisms that can easily be spread within microbial
communities. In Canada, poultry production involves more than 2600 regulated chicken
producers who have access to several antibiotics approved as feed additives for poultry.
Feed recipes and mixtures vary greatly geographically and from one farm to another,
making links between use of a specific antibiotic feed additive and production yields
or selection of specific antibiotic-resistant bacteria difficult to establish. Many on-farm
studies have revealed the widespread presence of antibiotic-resistant bacteria in broiler
chickens. While some reports linked the presence of antibiotic-resistant organisms to the
use of feed supplemented with antibiotics, no recent studies could clearly demonstrate
the benefit of antimicrobial growth promoters on performance and production yields. With
modern biosecurity and hygienic practices, there is a genuine concern that intensive
utilization of antibiotics or use of antimicrobial growth promoters in feed might no
longer be useful. Public pressure and concerns about food and environmental safety
(antibiotic residues, antibiotic-resistant pathogens) have driven researchers to actively look
for alternatives to antibiotics. Some of the alternatives include pre- and probiotics, organic
acids and essential oils. We will describe here the properties of some bioactive molecules,
like those found in cranberry, which have shown interesting polyvalent antibacterial and
immuno-stimulatory activities.
Keywords: growth promoters, non-therapeutic antibiotics, alternatives to antibiotics, cranberry, c-di-GMP, poultry
production, broilers
INTRODUCTION
Since the discovery of penicillin by Fleming in 1928, several
antibiotics which can be classified based on their molecular tar-
gets in bacteria (cell wall, protein synthesis, nucleic acids, folic
acid metabolism) have been marketed for the treatment of infec-
tious diseases both in animals and humans. The agents used in the
treatment of animals and humans often belong to the same classes
of antibiotics having similar modes of action and bacterial cell
targets. This interface brings a variety of problems and worries.
Bacteria developing resistance to these drugs in animals may be
transmitted to humans or spread their mechanisms of resistance,
which may eventually be found in human pathogens. Such a situ-
ationmay lead to the loss of therapeutic efficacy in both veterinary
and human medicine.
It is evident that antibiotics substantially improved pub-
lic health. For example, since their discovery about 70 years
ago, antibiotics have greatly reduced mortality and morbid-
ity associated with infectious diseases and have increased life
expectancy around the world. In addition to their therapeutic
use, antibiotics also are deployed in animals for prophylaxis and
growth promotion (improvement of animal zootechnical param-
eters). For example, antibiotics such as ceftiofur (a third genera-
tion cephalosporin), bacitracin (polypeptide) and virginiamycin
(streptogramin) are used in poultry production to respectively
prevent and control infections (respiratory diseases and necrotic
enteritis) and to improve food conversion and body-weight gain.
The use of antibiotics as growth promoters was adopted in the
1940s when animals fed dried mycelia of Streptomyces aureo-
faciens containing chlortetracycline residues showed improved
performances (Castanon, 2007). It has been estimated that antibi-
otic growth promoters in animals, through unspecific and not
well defined mechanisms, improve bodyweight by 5–6% and feed
efficiency by 3–4%, with the most pronounced effects observed
in young animals (Butaye et al., 2003). However, the deploy-
ment of antimicrobial agents can change the bacterial envi-
ronment by eliminating susceptible strains, and only allowing
antibiotic resistant bacteria (i.e., those with higher fitness) to
survive (O’Brien, 2002). Antimicrobial agents may thus modify
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the intestinal microflora and create a favorable environment for
establishment of resistant and pathogenic bacteria. Accordingly,
positive associations were found between the presence of certain
virulence genes and antibiotic resistance determinants (Aslam
et al., 2012; Johnson et al., 2012). The impact of antimicrobial
growth promoters on the development of antimicrobial resistant
bacteria has been the subject of several reports and led to their
ban in the European Union in 2006.
The poultry industry has grown and improved in recent years
due to the continuous integration of various disciplines for pro-
duction such as poultry health, nutrition, breeding, husbandry,
and knowledge of poultry products (Anonymous, 2007). For
example, in 1928, the average broiler required 112 days and 22 kg
of feed to reach 1.7 kg. Since 1990, broilers required about 35–42
days and 4 kg of feed to reach 2 kg (National Research Council,
1999). Even though this improvement could be attributable in
part to antibiotics, relevance of their use as growth promoters
in feed needs to be re-evaluated. With modern broiler produc-
tion practices, a broiler body weight of 1.8 kg can be reached by
using 3.2 kg of feed in 35 days without addition of any antibi-
otic in feed (Diarra et al., 2007). In this chapter, we will review
the use of antimicrobial agents in the Canadian poultry industry
and discuss public health issues and concerns related to antibiotic
resistant bacteria. We also will explore possible alternatives that
could be developed in respect to food and environmental safety
as well as to public and animal health and welfare.
ANTIBIOTIC SELECTIVE PRESSURE
The use of antibiotics as growth promoters is negatively per-
ceived because pathogenic bacteria of humans and animals have
developed and shared a variety of antibiotic resistance mecha-
nisms that can be easily spread within microbial communities.
Nowadays, worldwide spread of antibiotic resistance mechanisms
resulting from selective pressures (use of antibiotics) has undeni-
ably reduced treatment options and therapeutic efficacy in human
medicine. However, the relative responsibility of selective pres-
sures occasioned by human medicine, veterinary or agricultural
practices is still unclear. Furthermore, metagenomic studies have
established some links between resistance mechanisms found in
microorganisms from the environment and the clinic (Perry and
Wright, 2013), making even more difficult the identification of
the primary cause of selective pressure and support arguments for
multiple sources of antibiotic resistance genes (Lupo et al., 2012).
Transformation and conjugation are mechanisms accommo-
dating gene transfer among bacteria and are believed to play
important roles in the rapid spread of antibiotic resistance (Chen
et al., 2005). In addition, the horizontal transfer of mobile genetic
elements also contributes to the evolution of emerging pathogens
through dissemination of virulence genes. A variety of genetic
materials, such as plasmids, can participate to this evolution
(Carattoli, 2013). Moreover, integrative and conjugative elements
(ICEs) can be disseminated through transferable elements like
conjugative plasmids but can also integrate into the genome of
new bacterial hosts (Burrus and Waldor, 2004). Transposons are
also other mobile genetic elements that can contain antibiotic
resistance gene cassettes such as resistance integrons (Hall, 2012).
class 1 integrons, which can be disseminated through a wide
variety of taxonomically divergent bacteria, are often found in
bacteria associated with livestock and poultry (Mathew et al.,
2007). Another mean for gene transfer across bacterial species of
different taxa includes transduction (gene transfer mediated by
bacteriophages) as evidenced by using a metagenomic approach
for antibiotic resistance genes (Muniesa et al., 2013). Noteworthy,
antibiotic resistance gene transfer can be insidious as phenotypic
detection of inducible antibiotic resistance may be difficult and
may account for the “silent” spread of such genes in bacterial
communities (Chancey et al., 2012).
Hence, some bacterial isolates of animal origin might not be
pathogenic to humans but theymay carry and disseminate impor-
tant antibiotic resistance genes. For example, the same vanA gene
cluster involved in vancomycin resistance could be detected in
enterococci of both human and animal origins, indicating hori-
zontal transfer of gene clusters between enterococci of different
origins (Conly, 2002; Hammerum, 2012). Similarly, multidrug-
resistant commensal E. coli of animal origin represent an impor-
tant reservoir of antibiotic resistance genes that can be transferred
to other strains and bacterial species through contact with other
animals or humans and through contaminated food (Szmolka
and Nagy, 2013). Many food animals are now broadly recog-
nized as carriers of livestock-associated pathogens that can in
many occurrences cause diseases in the human host. For example,
Livestock-Associated Methicillin-Resistant Staphylococcus aureus
(LA-MRSA) have been transmitted from cows or pigs to humans
and could cause diseases (Witte et al., 2007; Garcia-Alvarez et al.,
2011; Laurent et al., 2012). Also recently, it was suggested that
multiple cases of community-acquired urinary tract infections
(UTI) caused by antibiotic-resistant bacteria could be consid-
ered outbreaks of foodborne origins (Nordstrom et al., 2013). In
Canada, studies suggested that poultry meats could play a role in
human infections (Manges et al., 2007) and that chicken repre-
sented the most probable reservoir of extraintestinal pathogenic
E. coli causingUTI (Bergeron et al., 2012). Certainly, in view of the
complexity of the antibiotic resistance spread allowed by various
means (genes, resistant commensals, or resistant pathogens) from
various reservoirs (food and environment), global coordinated
actions are required (Marshall and Levy, 2011; Laxminarayan
et al., 2013). Toward a global action in the Canadian poul-
try industry, at least two reasonable questions should arise. Are
antibiotics acting as growth promoters still needed nowadays?
What are possible alternatives to antibiotics that could be used
in preserving poultry health while maintaining farm profitability,
food safety and environmental health?
POULTRY INDUSTRY IN CANADA
According to the Food and Agriculture Organization (FAO) of
the United Nations, the world chicken production was esti-
mated at 71,851,372 tons in 2005, up 3% from the previous year
(Lacobucci et al., 2006). It is interesting to note that chicken pro-
duction has been grown steadily worldwide since the early 1990s.
From 1985 to 2005, 158% growth was recorded. The leading
chicken-producing countries include the United States, China,
the European Union and Brazil. In 2005, those four countries
or group of countries accounted for about 61% of world chicken
production. Canada was the thirteenth-largest chicken-producing
country in 2005 with 981.2 million kilograms representing 1.4%
of the world’s production (Lacobucci et al., 2006).
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Poultry production is an important industry in Canada. In
2012, the value of Canadian chicken products was estimated
at $2.4 billion, involving 2645 regulated chicken producers and
a large number of businesses associated with chicken farming
http://www.agr.gc.ca/poultry/index_eng.htm). In the same year,
Canada produced 1.02 billion kilograms of chicken (eviscer-
ated weight), 60% of which was produced in the provinces of
Quebec and Ontario. Canadian domestic consumption was 30
kilograms per person and retail purchases accounted for approxi-
mately 634 million kilograms representing 62% of Canada’s total
consumption. Canada exported over 5.9 million chicks to 13
countries; a commercial value estimated at over $14.5 million
in 2012. The United States was the largest market (91%). Other
countries included Mexico, Japan, the Philippines, and China
(http://www.agr.gc.ca/poultry/index_eng.htm).
In Canada, several medical ingredients are approved as feed
additives for poultry farmers. Among them, several classes
of antimicrobial agents, such as glycolipids (bambermycin),
polypeptides (bacitracin), ionophores (salinomycin), β-lactams
(penicillin), streptogramins (virginiamycin), and tetracyclines
(chlortetracycline) are used in broiler production for growth
promotion and prevention of infectious diseases (Table 1). For
broilers, salinomycin and bacitracin are widely used in starter,
grower or finisher feeds while virginiamycin is used in the finisher.
Many of the above antimicrobials are effective against Gram-
positive bacteria such as Clostridium perfringens, the etiological
cause of necrotic enteritis which is one of the main disease con-
cerns for poultry producers worldwide (Stutz et al., 1983; Heredia
and Labbé, 2001; Shojadoost et al., 2013). Since C. perfringens
also is one of the foodborne pathogens associated with poultry, it
is believed that antimicrobial agents targeting this pathogen also
help to prevent any potential food safety problems.
The preventive use of antibiotics in poultry production may
impact therapeutic efficacy in human medicine. Ceftiofur is a
third-generation cephalosporin, marketed for use in turkey, cat-
tle, swine, lambs, dogs, and horses. This antibiotic is often sub-
cutaneously injected in day old chicks (0.17mg/chick) or into
eggs (0.08–0.20mg) as a prophylactic measure in Canada to pre-
vent the yolk-sac infection (omphalitis), a costly disease caused
by Escherichia coli (Canadian Medical Association, 2009). This
use is under Canadian provincial regulations which differ from
province to province (Government of Canada, 2002). Overall
data on antibiotic use in Canadian hatcheries are not avail-
able; however, it seems that about 30% of the chicks hatched
in the province of Ontario would be treated mostly with ceftio-
fur followed by gentamicin (Rosengren et al., 2009). Ceftiofur
is not used in humans, however, its analog ceftriaxone, another
third-generation cephalosporin, is an important medical antibi-
otic used in humans. Resistance to these related antibiotics
can be mediated by similar mechanisms involving genes such
as blaCMY−2, an AmpC-type β-lactamase that hydrolyzes third-
generation cephalosporins.
In Canada as well as in several countries, various combina-
tions of antimicrobial agents are used in feed depending on birds’
ages, formulation and mixtures and such recipes greatly vary
geographically and from one farm to another. Hence, despite
the intuitive link between antibiotic usage in poultry and the
Table 1 | Agents approved as medicating ingredients in Canadian
poultry feed.
Agents Chicken Turkey
Arsanilic acid GP GP
Bacitracin (zinc or methylene disalicylate) GP, NE, EM GP
Zinc bacitracin and procaine penicillin EM
Bambermycin GP GP
Chlortetracycline hydrochloride GP, OT, ST CRD, GP, HE, NE,
OT, spE, ST
Oxytetracycline hydrochloride OT, ST CRD, OT, spE, ST,
SI, SY
Virginiamycin GP, NE
3-nitro-4-hydroxyphenylarsonic acid GP GP
Penicillin procaine GP
Amprolium CO CO
Clopidol CO
Decoquinate CO
Diclazuril CO CO
Halofuginone hydrobromide CO
Lasalocid sodium CO CO
Maduramicin ammonium CO CO
Monensin sodium CO CO
Narasin CO, NE
Narasin and nicarbazin CO
Nicarbazin CO
Robenidine hydrochloride CO CO
Salinomycin sodium CO
Semduramicin sodium CO
Zoalene CO CO
Hygromycin B WO
Piperazine WO WO
Tylosin phosphate NE
Nitarsone (4-Nitrophenylarsonic acid) BH
Novobiocin SY
Abbreviations: BH, blackhead; CO, coccidiosis; CRD, chronic respiratory disease;
EM, early mortality; GP, growth promotion and/or feed efficiency; HE, hexamitia-
sis; NE, necrotic enteritis; OT, other nutritional uses; spE, non-specific enteritis,
ST, stress; SY, synovitis; SI, sinusitis; WO, worms (Government of Canada,
2013a).
emergence of antibiotic resistant bacteria, variations in antimi-
crobial usage make links between the use of specific feed additives
and the selection of specific antibiotic resistant bacteria difficult
to establish (Diarrassouba et al., 2007). Furthermore, the origins
of antibiotic resistant bacteria remain uncertain and the sources
are certainly numerous (Marshall and Levy, 2011). Consequently,
antibiotic resistance in commensal enterococci can be found as
early as in 1-day old chicks (Table 2).
GROWTH PROMOTERS AND PERFORMANCE
Few studies have been performed to demonstrate the economic
benefits of antimicrobial growth promoters in the Canadian
poultry production system (Table 3). In controlled studies, the
effects of diet supplementation with bambermycin, penicillin,
salinomycin, bacitracin, salinomycin-bacitracin, virginiamycin,
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Table 2 | Antibiotic susceptibility phenotypes of some enterococci isolates from day-old chicks before placement and of some enterococci
isolates found in freshly manufactured feed (starter, grower, and finisher).
Antibiotic susceptibility phenotypeb
Categorya Antibiotic Day-old chick isolates Feed isolates
1 2 3 4 5 6 7 Starter Grower Finisher
I Ciprofloxacin R I S S S S S I S I
Daptomycin S S S S S S S S S S
Linezolid S S S S S S S S S S
Vancomycin S I S S I S I S S S
II Erythromycin R S R R I R S S S I
Gentamicin S S S S S S S S S S
Kanamycin R S R R S R S S S S
Lincomycin R R R R R R R R R R
Penicillin S S S S S S S S S S
Q/Dc R S R R S S S R S S
Streptomycin R S R R S R S S S S
Tylosin R S R R S R S S S S
III Chloramphenicol S S S S S S S S S S
Nitrofurantoin S S S S S S S I S S
Tetracycline R R R R R R R S S R
Bacitrcin R R R R R R R R R R
IV Flavomycin R S R R R R S R R R
aCategory indicates antibiotic ranking based on importance in human medicine.
bThe antibiotic susceptibility phenotypes are presented as S, sensitive; R, resistant; I, intermediary, using CIPARS susceptibility breakpoints (Government of Canada,
2013b).
cQuinupristin/Dalfopristin.
chlortetracycline, monensin, and narasin on body weight, feed
intake, feed efficiency, and mortality were evaluated (Diarra
et al., 2007; Bonnet et al., 2009). No significant difference was
noted between the treatment groups for the overall performance
although virginiamycin and penicillin improved feed efficiency.
The experiment conducted by Dumonceaux et al. (2006) found
that dietary inclusion of virginiamycin increased body weight and
improved feed efficiency from days 0 to 15 but that no difference
was noted for bird’s performance parameters for the remainder
of the study. The used of chlortetracycline as a feed supple-
ment at a rate permitted in Canada has been reported to induce
no significant improvement in 21- and 42-day old live body
weights or feed conversion efficiencies (Proudfoot et al., 1988).
Avoparcin an analog of vancomycin, has not been approved in
Canada, however, the growth promotion effect of this agent was
reported in experimental turkeys by a Canadian study (Leeson
and Summers, 1981). The economic effect of removing antibi-
otics used for growth promotion in commercial broiler chickens
was evaluated in a non-randomized study in the USA (Graham
et al., 2007). Positive production changes were associated with
the use of antibiotic agents, but these benefits were insufficient
to offset their cost (Graham et al., 2007). Well-designed on-farm
studies should be encouraged in the Canadian poultry production
system to support or not the use of growth promoting antimicro-
bial agents. With the improved hygienic and biosecurity practices
currently observed in modern poultry production, there is a gen-
uine concern that utilization of antibiotics as growth promoters
in feed might no longer be useful.
GROWTH PROMOTERS AND GUT MICROFLORA
The lives of human beings, livestock and poultry are closely asso-
ciated with microorganisms and the microbiota of their gut plays
an important role in their overall health, productivity and well-
being (Callaway et al., 2008; Ley et al., 2008). The growth of
normal intestinal bacteria varies with the gut environment, and
there is an increasing interest in the commensal components of
the gut microflora associated with food-producing animals (Yost
et al., 2011). Due to public and possible food safety and envi-
ronmental health concerns, the monitoring of the changes in
the microbiome (microbial genomes) as a function of chicken
production practices is imperative. Knowledge of the impacts
of antimicrobial agents on the gut microbiome might lead to
production practices that improve broiler intestinal health and
growth performances.
The use of virginiamycin as a growth promoter was associ-
ated with an increased abundance of bacteria in the duodenal
loop to proximal ileum, with fewer bacteria affected in the dis-
tal regions (ileocecal junction and cecum) indicating that vir-
giniamycin modifies the composition of the chicken intestinal
microbiota (Dumonceaux et al., 2006). Using the 16S rRNA
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Table 3 | Canadian studies evaluating growth promotion gains and health parameters of in-feed antibiotic supplementations.
References Promoter Route Study objectives Conclusions/Observations
Leeson and Summers,
1981
Avoparcin (10 ppm) and robenz
(33 ppm) alone or in combination
In-feed: Turkeys Performance and carcass
grades
Avoparcin improved weight gain
irrespective of coccidiostat robenz
inclusion. Feed utilization and carcass
grades were not influenced by diet
Proudfoot et al., 1988 Chlortetracycline (5.5mg/kg) In-feed: Broiler Growth promotion No further gain
Proudfoot et al., 1990 Lincomycin (2.2 ppm) In-feed or in
water: Broiler
Growth promotion No effect on mortality, efficiency of food
utilization, final body weights or monetary
indices
Dumonceaux et al., 2006 Virginiamycin (20 ppm) In-feed: Broiler Performance; intestinal
microbiota
Improved body weight and feed efficiency
from 0 to 15 days. Increased abundance
Lactobacillus spp. in the proximal
digestive tract with fewer targets affected
in the distal regions
Guban et al., 2006 Bacitracin and monensin alone or in
combination (0.5 g/kg)
In-feed: Broiler Growth performance;
population levels of
Lactobacillus salivarius;
bile salts deconjugation
Bacitracin increased feed intake and
decreased conversion ratio while
improving weight gain and concentrations
of conjugated bile salts. Monensin
increased fat digestibility. Antimicrobials
reduced populations of Lactobacillus
salivarius
Diarra et al., 2007 Bambermycin (2 ppm), penicillin
(2.2 ppm), salinomycin (60 ppm), and
bacitracin (55 ppm) or a combination
of salinomycin (60 ppm) + bacitracin
(ppm)
In-feed: Broiler Growth performances;
pathogen counts;
resistance phenotypes;
resistance determinants
Except for penicillin (improvement of feed
efficiency), no significant effect on
performance; no effect on bacterial count
in the intestine, ceca or litter. Significant
effect on antimicrobial resistance
phenotypes and genotypes
Brisbin et al., 2008 Virginiamycin (11 or 22 ppm) In-feed: Broiler Antibody response Enhancing systemic antibody responses
to some antigens
Gong et al., 2008 Bacitracin (50 ppm) In-feed: Broiler Ileum and caeca
microbiota
Alteration of the microbiota composition in
3-day-old chicks but no effect on the
microbial richness
Bonnet et al., 2009 Bambermycin (2 ppm); penicillin
(2.2 ppm); salinomycin (60 ppm); and
bacitracin (55 ppm); a combination of
salinomycin (60 ppm) + bacitracin
(ppm); chlortetracycline (110 ppm),
virginiamycin (11 or 22 ppm);
monensin (99 ppm); narasin (70 ppm)
In-feed: Broiler E. coli pathotypes and
phylogenetic group
Affect the phylogenetic group and
pathotypes distribution in the gut
Baurhoo et al., 2009 Mannanoligosaccharide (0.2 or 0.5%);
Virginiamycin (16.5 ppm); Bacitracin
(55 ppm)
In-feed: Broiler Performance; intestinal
development; cecal and
litter microbial
populations; carcass
parameters
No effect of antimicrobial on performance
and carcass. Some effect on cecal and
litter microbial population on day 34
Salim et al., 2013 Direct-fed microbial (DFM) such as
Lactobacillus reuteri (0.1%) or a
mixture of L. reuteri, Bacillus subtilis,
and Saccharomyces cerevisiae (0.1%);
Virginiamycin (0.1%)
In-feed: Broiler Performance; immune
response; cecal microbial
population; ileal
morphology
Increase performance from 0 to 21 days.
DFM increases white blood cells,
monocytes and the plasma
immunoglobulin concentrations while
decreases cecal E. coli population
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gene-based polymerase chain reaction followed by denaturing
gradient gel electrophoresis profiling, dietary treatment with bac-
itracin (50mg/kg) has been shown to alter the composition of
the microbiota but did not change its richness (Gong et al.,
2008). The authors demonstrated that the impact of bacitracin
was particularly obvious in 3-day-old chicks. Lactobacilli were
abundant in the cecal microbiota of 3-day-old chicks regard-
less of the dietary treatment with bacitracin (Gong et al., 2008).
Recently, metagenomic sequencing approaches demonstrated
that salinomycin-feeding (60 ppm) has a profound impact on the
dynamics of the chicken ceca microbiome (Fung et al., 2013).
These authors showed that the salinomycin fed group had an
increased abundance of the Elusimicrobia, and a decreased abun-
dance of Chloroflexi, Cyanobacteria, and Synergistetes. For exam-
ple, the abundance of Bifidiobacterium spp. and Lactobacillus spp.
increased significantly in the salinomycin-fed birds compared to
the untreated control group. A functional analysis of environmen-
tal gene tags (EGTs) revealed that in the salinomycin-treated birds
there was an increased abundance of the cell wall and capsule,
iron acquisition, motility and β-lactamase gene categories while
a decrease of multidrug efflux pump EGTs was detected (Fung
et al., 2013). In addition to such Canadian studies, other authors
demonstrated the impact of antimicrobial growth promoters on
the chicken gut microflora (Knarreborg et al., 2002; Torok et al.,
2011; Singh et al., 2013). For example, pyrosequencing followed
by phylogenetic analyses indicated that diet supplementation with
penicillin resulted in an elevated proportion of bacteria of the
phylum Firmicutes from 58.1 to 91.5% and a decreased propor-
tion of members of the phylum Bacteroidetes from 31.1 to 2.9%
in the gut microflora of broilers compared to that observed in
broilers fed with the control non-supplemented diet (Singh et al.,
2013). Besides, the decrease of broiler ileal sucrase and maltase
activities and increase of ileal mucosal immunoglobulin A (IgA)
as well as the increase of Lactobacillus counts were suggested to
be among the effects of bacitracin (55 ppm) and oxytetracycline
(2.5 ppm) that could explain the improvement of feed efficiency
in broilers from days 0 to 21 (Lee et al., 2011).
GROWTH PROMOTERS AND RESISTANCE
The use of antibiotics in poultry production and the attendant
selection of resistant bacteria has been the subject of numer-
ous studies (Aarestrup, 2000; Angulo et al., 2000; O’Brien, 2002;
Butaye et al., 2003; Asai et al., 2005; Anonymous, 2007; Castanon,
2007; Diarra et al., 2007; Diarrassouba et al., 2007). However,
besides the simple principle that exposure to an antimicrobial
agent can select for a resistant bacterium, the selection and dis-
semination of antimicrobial resistance is a complex phenomenon,
which should be examined with ecological and population per-
spectives. Several studies have shown the presence of antibiotic
resistant bacteria (E. coli, Salmonella serovars; Enterococcus spp.,
C. perfringens) in Canadian poultry (Diarrassouba et al., 2007;
Diarra et al., 2010; Slavic et al., 2011; Agunos et al., 2012; St.
Amand et al., 2013).Many antibiotic resistance genes in these bac-
teria have been identified onmobile genetic elements such as plas-
mids, transposons and integrons, allowing their dissemination
among bacteria in the chicken gut or in extra-intestinal environ-
ments. However little is known about the selection, distribution
and dissemination of antibiotic resistance genes in Canadian
broiler chicken productions in relation to the use of specific
therapeutic agents or antimicrobial growth promoters.
Recently, the Canadian Integrated Program for Antimicrobial
Resistance Surveillance (CIPARS) reported a possible association
between ceftiofur-resistant Salmonella enterica serovar Heidelberg
isolated from retail chicken meats and the incidence of ceftiofur-
resistant Salmonella Heidelberg infections in humans across
Canada (Dutil et al., 2010). In the province of Quebec, the
prophylactic use of ceftiofur in broiler chickens coincided with
the rise of the prevalence of ceftiofur resistance in Salmonella
that significantly decreased following voluntary withdrawal of
this antibiotic (Rosengren et al., 2009). In relation to this,
it is noteworthy to mention that the presence of β-lactam
resistant Salmonella enterica serovars Kentucky, Typhimurium,
Enteritidis, and Heidelberg that harbored a variety of important
β-lactamase genes (CMY, TEM, SHV) either alone or in combina-
tion with other resistance genes were reported in chickens (Diarra
et al., 2014). This observation is of concern because the use of
cephalosporins at therapeutic levels can decrease the susceptibil-
ity to other antibiotics such as tetracycline and amikacin which
resistance genes can be co-located on CMY-2 plasmids (Hamilton
et al., 2012).
Using antimicrobial agents in feed, it was demonstrated that
multi-antibiotic-resistant E. coli can colonize and persist in the
broiler gut. Of 256 E. coli isolates analyzed usingDNA-microarray,
88% possessed at least one antimicrobial resistance gene with
42% showing multiple resistance genes (Diarra et al., 2007). The
bacterial phenotypes and distribution of resistance determinants
in E. coli were found to be modulated by feed supplementation
with some of the antimicrobial agents used in broiler chicken
production (Diarra et al., 2007; Thibodaux et al., 2008; Bonnet
et al., 2009). In E. coli, class 1 intregron and the aminogly-
cosides resistance aadA gene were predominantly found in the
isolates from bacitracin and salinomycin treatments (Diarra et al.,
2007), while the streptogramin resistance vatD gene was more
prevalent in enterococci isolated from virginiamycin-treated birds
compared to that found in the control birds (Thibodaux et al.,
2008). Detailed antibiotic resistance genotypes of a variety of
enterococci isolated from the feces and ceca of Canadian com-
mercial broiler chickens were reported (Diarra et al., 2010). Genes
conferring resistance to aminoglycosides (aac, aacA-aphD, aadB,
aphA, sat4), macrolides (ermA, ermB, ermAM, msrC), tetracy-
cline (tetL, tetM, tetO), streptogramins (satG_vatE8), bacitracin
(bcrR), and lincosamide (linB) were detected in corresponding
resistant E. faecium and E. faecalis strains (Diarra et al., 2010).
Although food-producing animals are not considered as a source
of Enterococcus infection in humans, antibiotic-resistant ente-
rococci from these animals may transfer their resistance genes
to bacterial strains infecting humans. Thus, the prevalence of
antibiotic-resistant enterococci, in poultry can constitute a seri-
ous public health problem.
Accurate estimates of the volume of antimicrobials specifi-
cally used as growth promoters in Canadian animal productions
including poultry is lacking. According to the Canadian Institute
of Animal Health estimates reported par CIPARS (Government
of Canada, 2013b), a total of 1,766,126, 1,617,747, 1,615,571, and
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1,632,364 kg of antimicrobials were distributed in Canada for use
in animals in 2006, 2007, 2008, and 2009, respectively. During
these years, tetracyclines which are broad spectrum agents, ranked
first with 48.0, 46.6, 42.1, and 42.1% of all antimicrobials being
used in 2006, 2007, 2008, and 2009, respectively. The total
amount of tetracyclines used specifically in poultry production is
unknown. However, a high prevalence of tetracycline resistance in
both Gram negative and Gram positive bacteria has been reported
in Canadian poultry farms and poultry meats which could be
related to the extensive used of this antibiotic.
In Gram negative bacteria such as E. coli, tetracycline resis-
tance is frequently mediated by several efflux genes. The tetB,
one of such genes, seems to be the most prevalent in E. coli iso-
lated from Canadian broilers (Diarrassouba et al., 2007; Bonnet
et al., 2009). The tetracycline resistance genes can be associated
with large plasmids, which often carry other antibiotic resistance
genes, heavy metal resistance genes, and/or other pathogenic fac-
tors such as toxins (Forgetta et al., 2012). Hence, selection for any
of these factors selects for these plasmids. Associations between
the β-lactamase (tem), tetracycline (tet), sulfonamide (sulI or
sulII), aminoglycoside [ant(3′′)-Ia (aadA)] and phenicol resis-
tance (floR) genes and class 1 integrons were reported in E. coli
isolated from broilers (Diarra et al., 2007). These associations
increase the risk of selection and dissemination of resistance.
In Gram positive bacteria, the tetL gene encodes a large pro-
tein which confers resistance to tetracycline by active efflux while
tetM encodes a cytoplasmic ribosome protecting protein also
leading to resistance. The tetL and tetM genes were the most
frequently found in association with the ermB gene (encod-
ing resistance to macrolide, lincosamide and streptogramin B
quinupristin-dalfopristin) and the bacitracin resistance gene bcrA
in enterococci isolated from broiler chickens (Diarra et al.,
2010). As mentioned above, bacitracin is one of the antimicro-
bial agents used as a growth promoter and to prevent necrotic
enteritis (Table 1). The use of this antibiotic can co-select for
resistance to other unrelated antibiotics as well, which demon-
strates that the spread of antimicrobial resistance is a complex
phenomenon.
The origin of the antimicrobial resistant bacteria colonizing
the broiler gut needs to be established. In our laboratory, exami-
nation of the gut contents of day-old chicks revealed the presence
of about 1.6 Log CFU of enterococci spp. per gram (Diarra,
unpublished data). Some of these isolates were multi-resistant
to bacitracin, ciprofloxacin, erythromycin, tylosin, flavomycin,
streptomycin, kanamycin, lincomycin, quinupristin-dalfopristin,
and tetracycline (Table 2). In Canada and other countries where
poultry production is intensive, high numbers of broilers are
raised in confined and non-sterile environments. Broilers can
be exposed to such environmental bacteria among which some
could be resistant. For example, chicken feed has been shown
to contain E. coli, Klebsiella and Pseudomonas spp. isolates resis-
tant to four to nine antibiotics (Saleha et al., 2009). In another
study, examination of 23 commercial broiler feed samples and
of 66 samples of raw feeding materials revealed that feedstuffs
and poultry feed are extensively contaminated with resistant ente-
rococci in agreement with our observations (Table 2) and, to a
lesser extent, by E. coli (da Costa et al., 2007). Note that other
factors also contribute to bacterial gut colonization such as the
age of the animals and the microflora may thus vary over time.
This should be taken into account when assessing antimicrobial
resistance prevalence.
ENVIRONMENTAL PERSPECTIVES
Poultry litter, a mixture of materials including bedding, feces and
feathers, is a valuable soil amendment that is rich in nutrients and
can improve soil physical, chemical, and biological properties for
agricultural crops (Brye et al., 2004). Most of the antimicrobial
agents administrated through feed or water are not fully absorbed
in the chicken gut and up to 90% of the administered dose of
some of the antimicrobials can be excreted in the feces. Residues
of chicken feed additives such as bacitracin, chlortetracycline,
monensin, narasin, nicarbazin, penicillin, salinomycin, and vir-
giniamycin can be detected in the litter at concentrations ranging
from 0.07 to 66mg/L depending on the compounds (Furtula
et al., 2010). Such a litter, if not treated to remove these com-
pounds, may be an important source of antimicrobial residues
when used as fertilizer. These residues also could contribute in
the selection of antibiotic resistant bacteria as demonstrated for
ceftiofur residues by Call et al. (2013).
Litter can be a source of antimicrobial resistant bacteria as well.
Various antibiotic resistant E. coli strains harboring genes con-
ferring resistance to β-lactams (blaCMY−2, blaTEM), tetracycline
(tetAB) and streptomycin (strAB) have been reported to survive
for several months in soil following late summer litter applica-
tion (Merchant et al., 2012). Estimating survival of antibiotic
resistant and potential pathogenic bacteria in soil amended with
raw untreated litter from broiler fed antimicrobial supplemented
diets is essential for developing intervention strategies against
resistant pathogens and toward pathogen control in agricultural
soils.
Drinking water should be very low in bacterial counts and no
pathogenic microorganism should be detected in it. From 2005
to 2006, a bacteriologic study on 353,388 drinking water sam-
ples from private wells in Alberta and Ontario found that 4.6% of
these samples were contaminated with E. coli. Antibiotic suscepti-
bility tests done on 7063 of these E. coli isolates showed that 10.5%
were resistant mainly to tetracycline, sulfonamides, β-lactams or
aminoglycosides (Coleman et al., 2013). These authors reported
that such antibiotic resistant E. coli were more commonly isolated
from farms housing chickens or turkeys than from properties
without poultry.
Primary biological aerosols (airborne biological particles
derived from, or which are composed of living microorganisms)
are of special concern in poultry barns and slaughterhouses,
where the high number of chickens handled in these facilities
leads to the presence of substantial concentrations of bacteria and
other microorganisms in air (Donham et al., 2000). Antibiotic-
resistant bacteria have been reported in broiler chicken air
(Brooks et al., 2010; Vela et al., 2012). Biofilm forming staphylo-
cocci harboring genes conferring resistance to tetracycline (tetK),
lincomycin (linA), erythromycin (ermB), and β-lactams (blaZ)
were isolated from air inside and outside broiler production facil-
ities (Vela et al., 2012). The airborne dispersion of antimicrobial
resistant bacteria should not be underestimated since the presence
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of pathogenic bacteria in air represents a potential risk to poultry
farm workers and to people working or living near these facilities.
CONCERNS ABOUT FOOD SAFETY AND SPREAD OF
ANTIBIOTIC RESISTANCE
Antibiotic-resistant bacteria constitute a major food safety issue.
Antibiotic-resistant bacterial pathogens such as Salmonella or
E. coli can infect humans through contact or consumption of
contaminated food while non-pathogenic resistant isolates can
transfer their resistant genes to human pathogens. Although mul-
tifactorial, practices contributing to the selection of antibiotic
resistant bacteria include antibiotic use in livestock feed, and
concerns about food safety and reduced efficacy of antibiotic
treatment in human medicine have stimulated expert groups to
action (Mathew et al., 2007; Laxminarayan et al., 2013).
Antibiotic resistance has become a worldwide threat to pub-
lic health. For example in the United States of America (USA),
according to a recent report from the Centers for Disease Control
and Prevention (CDC), at least 2 million people become infected
with “antibiotic resistant bacteria” among which at least 23,000
people die each year as a direct result of these infections (CDC,
2013). The USA National Antimicrobial Resistance Monitoring
System (NARMS) assisted by the Food and Drug Administration
(FDA) and the Department of Agriculture (USDA), monitor
antimicrobial susceptibility of enteric bacteria from humans,
retail meats and food-producing animals, in order to make deci-
sions related to the approval of safe and effective antimicrobial
drugs for animals (NARMS, 2012). In Canada, the Public Health
Agency of Canada and the CIPARS track antimicrobial resistance
to generate data helping to limit the spread of antibiotic resistant
bacteria. More so, initiatives that collect data on commensal and
environmental strains as reservoirs of antibiotic resistance genes
are invaluable (Marshall and Levy, 2011). It is thought that the
frequency of resistance genes in commensals may act as a marker
of the emergence of resistance in pathogens (www.roarproject.
org).
Concerns for safe food and effective medical antibiotics have
pressured authorities for elimination of antibiotics as growth
promoters as well as those of medical importance in animal pro-
duction. Despite incomplete data, there were sufficient genuine
and reasonable arguments for implementing such regulations in
the European Union and similar policies and recommendations
in North America were made based on the precautionary prin-
ciple. For example, the CDC supports the strategy of the FDA
to promote the judicious use of antibiotics that are important
in treating humans. In Canada, there is a variety of efforts that
follow this trend (Agunos et al., 2012). The Canadian Veterinary
Medical Association is developing prudent and judicious antimi-
crobial use guidelines for veterinarians working with swine,
beef or dairy herds and poultry flocks. The Veterinary Drugs
Directorate (VDD) of Health Canada, which is responsible for
the approval and registration of all antimicrobials for use in agri-
culture, is developing a risk management strategy to reduce the
human health impact of antimicrobial resistance due to use of
antimicrobials in animals.
Still, efficient control of foodborne pathogens remains a con-
cern (Smadi and Sargeant, 2013) and removal of non-therapeutic
antimicrobials from animal production may possibly increase the
prevalence of pathogens in the animal gut and the frequency
of foodborne illnesses. Alternatives to antibiotics are therefore
required.
ALTERNATIVES TO ANTIBIOTICS
Public pressure and concerns about food and environmen-
tal safety (antibiotic residues, spread of antibiotic genes and
antibiotic-resistant pathogens) have driven researchers to actively
look for alternative approaches that could eliminate or decrease
the use of antibiotics while maintaining production yields and
low mortality in poultry production. As discussed in previ-
ous sections, the biological basis for antibiotic effects on ani-
mal growth efficiency is most likely derived from effects on
the intestinal microbiota, which in turn may reduce oppor-
tunistic subclinical infections, reduce the host response to the
gut microflora, decrease competition for nutrients, and improve
nutrient digestibility consequent to a reduction in some micro-
bial fermentation by-products (Dibner and Richards, 2005). With
such pleiotropic effects, it will be difficult to find alternatives to
antimicrobials administered for prevention or provided as growth
promoters in feed.
Several alternative strategies to antibiotics in poultry and live-
stock production are under investigation (Dahiya et al., 2006;
Zakeri and Kashefi, 2011; Seal et al., 2013). Individual strate-
gies examined included direct-fed microbial (probiotics) and live
microbial feed supplements which beneficially affect the host ani-
mal by improving its intestinal balance (Rajput et al., 2013; Salim
et al., 2013); prebiotics, indigestible feed ingredients that ben-
eficially affect the host by selectively stimulating the activity of
beneficial bacteria resident in the animal tract (Patterson and
Burkholder, 2003; Baurhoo et al., 2009; Samanta et al., 2013); vac-
cination (Desin et al., 2013) and immune-stimulation through
cationic peptides and cytokines (Asif et al., 2004; Kogut et al.,
2013); bacteriocins and antimicrobial peptides (Joerger, 2003;
Svetoch and Stern, 2010); bacteriophages (Huff et al., 2005, 2013;
Zhang et al., 2013); organic acids with antimicrobial activities;
herbs, spices and other plant extracts (González-Lamothe et al.,
2009); and controlled organic productions with emphasis on diet
formulation and ingredient selection, cereal type and dietary pro-
tein source and level (Drew et al., 2004; O’Bryan et al., 2008).
To date, none of these strategies have been systematically imple-
mented. Consequently, exploration for new approaches to pre-
vent poultry diseases and colonization of poultry by foodborne
pathogens is continuing worldwide.
BERRIES AS A GENERIC SOURCE OF BIOACTIVE MOLECULES
Natural products as tools for disease prevention and health main-
tenance have reached public acceptance leading to an accelerated
research in this area. There are now abundant reports of plant
products with bioactivities against a wide variety of pathogenic
bacteria. Multiple classes of antibacterial products, including
phenolic acids and polyphenols, phenanthrenes, flavonoids, and
terpenoids have been described and reviewed (González-Lamothe
et al., 2009).
Some products may have antibacterial activities of their own
by significantly altering growth or bacterial cell structures. Others
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which may be defined as “antibiotic potentiators or adjuvants”
could allow reduction of antibiotic usage. Some may have anti-
virulence effects or alter quorum-sensing necessary for efficient
pathogenesis. Besides, others, defined as “immuno-stimulants”
could assist the host immune system to adequately respond to
the pathogen invasion, while others may positively affect the
intestinal microbiota. Knowing that subclinical diseases caused
by pathogens can impact productivity, this review presents
some results on the potential of cranberry extracts to control
pathogenic bacteria.
Cranberries, Vaccinium macrocarpon Aiton (Ericales:
Ericaceae), are indigenous to wetlands of central and eastern
North America (Eck, 1990). Canadian cranberry productions
increased from 95,655 tons in 2009 to 134,575 tons in 2013. Most
of the productions come from British Columbia, Quebec, New
Brunswick, Nova Scotia and Prince Edward Island (Statistics
Canada, 2013). Polyphenolic compounds are widely distributed
in higher plants and are integral parts of the human diet. An
important and often overlooked group of polyphenols is the
proanthocyanidins (condensed tannins).
Particular interest is being shown in the proanthocyanidins
from cranberry (Foo et al., 2000). Flavonoids in cranberry may
reduce or prevent atherosclerosis by preventing oxidation of low
density lipids (Reed, 2002). Cranberry proanthocyanidins at a
concentration of 75μg/mL were found to inhibit the adher-
ence of E. coli to urinary epithelial cells, preventing or miti-
gating thus UTI (Foo et al., 2000; Howell and Foxman, 2002).
Cranberry extracts were also reported to inhibit the sialyllactose-
specific adhesion of Helicobacter pylori to immobilized human
mucus, erythrocytes, and cultured gastric epithelial cells (Burger
et al., 2002). Because the inhibitors of adhesion are not neces-
sarily bactericidal, the selection of resistant strains is unlikely to
occur and anti-adhesion agents represent an interesting thera-
peutic strategy (Sharon and Ofek, 2002). The potential of plant
tannins, including proanthocyanidins, as alternatives to growth
promoters in poultry has recently been reviewed by Redondo
et al. (2014). It is expected that the value of cranberry-based
food and nutraceutical products will remain high as health
benefits of cranberry become more firmly established. Recent
studies suggest that the potential health effects of cranberry
are associated with its phytochemical constituents (Blumberg
et al., 2013). Furthermore, studies have revealed that extracts
from these sources can affect various bacterial functions includ-
ing disruption of their cell envelope, which parallels that of
some antibiotics widely used as growth promoters in the poultry
industry.
It has however been difficult to isolate specific active compo-
nents from plant extracts which often consist of a mixture of a
large number of structurally related compounds (Puupponen-
Pimiä et al., 2005). These compounds have varying degrees of
bioactivity or even opposing effects (growth inhibitors vs. growth
stimulants) and even some with cytotoxicity (Jaki et al., 2008).
Also, the spectrum of activity or the mode of action of purified
components is often very narrow or non-specific and the use of
berry extracts or pomace containing mixtures of bioactive com-
pounds has become an attractive alternative to create an added
value to berry by-products.
The antimicrobial activities of cranberry extracts were evalu-
ated against important pathogenic Gram negative bacteria such
as E. coli and Salmonella enterica serovar Typhimurium, which
is often associated with poultry (Wu et al., 2008; Harmidy
et al., 2011). It has been reported that treatment with cranberry
proanthocyanidins (CPACs) inhibited Salmonella invasion and
enteropathogenic E. coli pedestal formation, likely by perturb-
ing the host cell cytoskeleton by CPACs rather than by an effect
on bacterial virulence itself (Harmidy et al., 2011). Dehydrated,
crushed cranberries or purified CPACs were also shown to inhibit
the expression of the flagellin gene (fliC) in uropathogenic E. coli
(Hidalgo et al., 2011).
In order to study the pleiotropic effects of cranberry extracts
on E. coli, we (Gattuso et al., 2008) and others (Lin et al., 2011)
have used a DNA array-based approach in an attempt to corre-
late specific transcriptional signatures with modes of action. The
effects observed on the transcriptome of E. coli exposed to cran-
berry extracts correlated with known characteristics of cranberry
constituents such as condensed tannins (flavonoids) and pheno-
lic acids that could possibly act as iron chelators. In view of these
results, cranberry extracts could be used to perturb bacterial iron
homeostasis and improve nutritional immunity in the gut (Hood
and Skaar, 2012).
Based on our own experience, commercially available cran-
berry products like Nutricran®90 (NC90) and some of our
own cranberry extracts yielded stronger growth inhibition effects
against Gram positive pathogens such as Staphylococcus aureus
(Diarra et al., 2013), Listeria monocytogenes (Block et al., 2012),
and Clostridium perfringens (Delaquis et al., 2010), although the
minimal inhibitory concentrations of the cranberry products
were several times higher than that of conventional antibiotics
such as penicillin. Similarly to work done with E. coli, transcrip-
tional analyses by microarrays allowed determining the modes of
action of the cranberry product NC90 against S. aureus (Diarra
et al., 2013). The effect of cranberry on the S. aureus transcrip-
tome yielded the identification of several bacterial genes known
to be up-regulated by the presence of cell-wall acting antibi-
otics, such as oxacillin, vancomycin, and daptomycin (Singh et al.,
2001; Utaida et al., 2003; Muthaiyan et al., 2008), as represented
in Figure 1. More specifically, a group of genes known as the
cell wall stress regulon was strongly up-regulated and clearly
demonstrated an effect of cranberry on S. aureus cell wall biosyn-
thesis. Ethanol extraction of pomaces (pressed cakes) from fresh
fruits also produced a cranberry fraction (FC111) modulating
the same marker genes as demonstrated by qPCR. S. aureus cell
surface disruption by cranberry is also supported by work from
Wu et al. (2008) and by cell wall biosynthesis assays (Diarra
et al., 2013). Besides, it was noted that NC90 and FC111 also
modulated the expression of some S. aureus genes (like lytM,
Figure 1) that respond to membrane depolarization, as provoked
by carbonyl cyanidem-chlorophenylhydrazone (CCCP) and dap-
tomycin (Muthaiyan et al., 2008). Interestingly, cranberry extracts
also strongly down-regulated capsular biosynthesis genes, an
effect that was corroborated by electron microscopy (Figure 1).
Listeria spp. are important foodborne pathogens that can be
associated with various foods including fresh and frozen meat
and poultry. Cranberry fraction FC111 also showed bactericidal
www.frontiersin.org June 2014 | Volume 5 | Article 282 | 9
Diarra and Malouin Antibiotics in Canadian poultry productions
FIGURE 1 | Venn diagrams showing some of the S. aureus genes up-
and down-regulated following exposure to cranberry (left). The
transcriptional signature resembles to that of the cell wall stress stimulon
provoked by peptidoglycan biosynthesis inhibitors such as vancomycin,
oxacillin, and to some extent daptomycin. Compounds causing membrane
depolarization like daptomycin and CCCP also share a common
transcriptional signature with cranberry. Genes up- and down-regulated are
represented by up and down arrows, respectively. Genes affected by
cranberry also include those involved in capsular polysaccharide
biosynthesis (Diarra et al., 2013), which correlates with the presence of a
thinner capsule at the surface of S. aureus (lower right panel compared to
the untreated control, top right panel). The capsule material (indicated by
arrows) was labeled using polycationic ferritin as described before (Diarra
et al., 2002).
effects as well as antibiofilm formation activities against Listeria
monocytogenes (Block et al., 2012). Apostolidis et al. (2008)
reported a proline dependent inhibition of L. monocytogenes by
combinations of phenolic extracts of oregano and cranberry in
both broth and cooked meat studies. These data indicate that
further examination of the antimicrobial potential of cranberry
extract is warranted (Wu et al., 2008).
The multiple biological effects of cranberry observed against
E. coli, Salmonella, S. aureus, C. perfringens, and Listeria, certainly
reflect the complexity of its composition and physical properties.
The cranberry tannins include polyphenols and more specifi-
cally anthocyanins, flavonols and flavan-3-ols (Puupponen-Pimiä
et al., 2005). Flavonoids, including anthocyanins and proantho-
cyanidins, are believed to be the major antimicrobial components
(Puupponen-Pimiä et al., 2001). At this time, our mass spectrom-
etry analysis of cranberry fraction FC111 could not determine if
the observed antibacterial activity originates from iridoids, phe-
nolics, or flavonoid components. Besides, we showed that the
cranberry fraction FC111 obtained from pomace is an excel-
lent natural polyphenolic product with potent antioxidant and
vasorelaxant properties (Harrison et al., 2013), which combined
with its antibacterial activities might represent an interesting
alternative in poultry production. In this regard, a poultry feed-
ing trial using a commercial whole cranberry fruit extract showed
that a concentration of 40mg of cranberry extracts per kg of
feed induced low early mortality rates (improvement by 40%
compared to the control) in birds. The mechanism of action
leading to this improvement remains to be determined. However,
diet supplementation with such extracts caused a shift of the
intestinal tract bacterial population while not altering any broiler
meat properties (Leusink et al., 2010).
CYCLIC DIGUANOSINE MONOPHOSPHATE (C-DI-GMP)
c-di-GMP is a bacterial intracellular second messenger control-
ling diverse bacterial processes. This molecule is important for a
wide range of pathogenic agents as it is involved in the modula-
tion of the infection process through modulation of motility, cell
adhesion and biofilm formation (Tamayo et al., 2007; Bordeleau
et al., 2011). However, c-di-GMP is also a potent immuno-
stimulatory agent that can modulate the host immune response
and several reports demonstrated its adjuvant and therapeutic
properties (Brouillette et al., 2005; Karaolis et al., 2007; Ogunniyi
et al., 2008; Hu et al., 2009). Moreover, the ability of c-di-GMP
as a mucosal adjuvant was also documented (Ebensen et al.,
2007; Zhao et al., 2011). c-di-GMPmight thus represent an inter-
esting alternative to non-therapeutic antibiotics used in poultry
production.
The infectious bursal disease virus (IBDV, Gumboro dis-
ease) is one of the major immuno-suppressive viruses affecting
broilers. This virus is highly contagious and represents a major
economic threat in poultry production worldwide (Bumstead
et al., 1993). Since the effects of c-di-GMP on chicken immune
responses had not yet been investigated, we evaluated the humoral
immune response following oral administration or intramuscular
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injection of c-di-GMP in conjunction with the IBDV vac-
cine S-706 in broiler chickens (Fatima et al., 2011). Results
indicated that c-di-GMP stimulated IgA production in serum
and confirmed the potential of this molecule as a mucosal
adjuvant.
Asmentioned above, an enteric pathogen of particular concern
in poultry is C. perfringens Type A, the causative agent of necrotic
enteritis (Timbermont et al., 2011). Hence, in an effort to explore
strategies to controlC. perfringens, we investigated the potential of
c-di-GMP in a broiler challenge model (Fatima et al., 2013). We
found that c-di-GMP can modulate C. perfringens colonization
in the host ceca with no noticeable effect on the microbiota and
the commensal bacterial community of the intestine. It will be
interesting to investigate in more details the value of c-di-GMP as
an in-feed additive in poultry production.
CONCLUSION
Antibiotics are important tools for the treatment of old and
emerging infectious diseases. Their efficacy for this purpose
should be preserved as it is now well documented that their
abusive and inappropriate use in humans, livestock and poul-
try selects for antibiotic resistant bacteria, compromising thus
their therapeutic efficacy. One of questionable practices in ani-
mal agriculture is the use of non-therapeutic antimicrobials for
growth promotion. Even if this practice was determinant in the
past, its advantage in current modern agriculture including poul-
try production needs to be re-evaluated because of the actual
prevalence of antibiotic resistant bacteria in livestock and poultry
and their products worldwide. The presence of multi-drug resis-
tant commensal bacteria (Escherichia spp., Enterococcus spp.) and
foodborne pathogens such as non-typhoid Salmonella associated
with poultry are some of the examples among others. It is imper-
ative to determine the exact sources and ecology of these resistant
bacteria in order to develop strategies to stop their spread. It is
also urgent to develop alternatives to antimicrobial growth pro-
moters that will not compromise livestock and poultry health
as well as the actual industry productivity. Canadian studies in
this area identified some promising sources of alternatives to
antibiotics which have been discussed here.
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